000 01262 a2200361 4500
005 20250512173434.0
264 0 _c19681024
008 196810s 0 0 eng d
022 _a0008-543X
024 7 _a10.1002/1097-0142(196809)22:3<525::aid-cncr2820220306>3.0.co;2-c
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSamuels, M L
245 0 0 _aMedroxyprogesterone acetate in the treatment of renal cell carcinoma (hypernephroma).
_h[electronic resource]
260 _bCancer
_cSep 1968
300 _a525-32 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAcetates
_xadministration & dosage
650 0 4 _aAdenocarcinoma
_xdrug therapy
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aKidney Neoplasms
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMedroxyprogesterone
_xadministration & dosage
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Metastasis
_xdrug therapy
650 0 4 _aTestosterone
_xadministration & dosage
700 1 _aSullivan, P
700 1 _aHowe, C D
773 0 _tCancer
_gvol. 22
_gno. 3
_gp. 525-32
856 4 0 _uhttps://doi.org/10.1002/1097-0142(196809)22:3<525::aid-cncr2820220306>3.0.co;2-c
_zAvailable from publisher's website
999 _c5673939
_d5673939